Scientia Ventures
Overview
Scientia Ventures invests in early to mid-stage technology companies that target computational biology and chemistry, the digitization of medicine, and digital therapies as well as traditional drug development companies at the cutting edge of the life sciences . They build new companies around innovations they identify and partner with existing companies to accelerate growth and commercialize their innovative products/services .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Emerald | Oct 2026 | Grant | Co-investor |
| Intelinair | Sep 2021 | Series B | Lead |
| Enterin | Jul 2017 | Series A | Co-investor |
| 1910 Genetics | Mar 2021 | Series A | - |
| Drumroll Snacks | Oct 2024 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Scientia Ventures based?
Scientia Ventures is headquartered in New York City, New York, United States.
When was Scientia Ventures founded?
Scientia Ventures was founded in 2006.
How many portfolio companies does Scientia Ventures have?
Scientia Ventures has 5 portfolio companies in Caplight's dataset.
What are some companies in Scientia Ventures's portfolio?
Portfolio companies visible on Caplight include Emerald, Intelinair, Enterin, 1910 Genetics, Drumroll Snacks.
What was Scientia Ventures's most recent investment shown here?
Scientia Ventures's most recent investment in this portfolio sample was in Emerald in 2026.
What sectors does Scientia Ventures focus on?
Scientia Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Scientia Ventures focus on?
Scientia Ventures typically invests at the Early stage.
What is Scientia Ventures's AUM?
Scientia Ventures's assets under management are estimated between $100.0M and $250.0M.